Erectile dysfunction drug ‘could prevent hand, finger ulcers’
November 8th, 2010 - 1:19 pm ICT by ANIWashington, Nov 08 (ANI): A research has suggested that adding tadalafil to the treatment of people with scleroderma can improve Raynaud’s phenomenon symptoms and heal and prevent hand and finger ulcers associated with it.
Scleroderma is a rheumatic disease that results in the thickening and tightening of skin, as well as a build-up of scar tissue and damage to internal organs.
Most patients with scleroderma also suffer from Raynaud’s phenomenon - structural damage of the blood vessels that cause them to react abnormally to the cold. Raynaud’s phenomenon is commonly marked by discoloration of the hands, fingers and toes.
Researchers studied 53 patients-of which 50 were women-whose average age was almost 37 years and who had suffered from scleroderma, on average, for almost six years. Twenty-six of the participants had limited scleroderma (which only occurs in the forearms, hands, legs, feet and face) and 27 had diffuse scleroderma (which can affect almost any area of the body).
Researchers noticed that improvement in the tadalafil group was significantly better than in the placebo group. At the beginning of the study, 18 patients in the tadalafil group had ulcers as compared to 13 patients in the placebo group.
Following treatment with tadalafil, 14 out of 18 of those patients healed completely as compared to five out of 13 patients in the placebo group. Further results revealed that new ulcers appeared in only one patient in the tadalafil group as compared to nine patients in the placebo group.
Additionally, other symptoms such as dyspnea (difficulty breathing), Raynaud’s phenomenon and digital ulcers were greatly improved in those taking tadalafil. Finally, researchers noted that side effects were similar in both groups and no serious side effects were observed.
“Tadalafil, in combination with other vasodilators, not only improves the number, duration and severity of Raynaud’s attacks, but also heals the existing digital ulcers as compared to placebo,” explained Vikas Agarwal,
associate professor of clinical immunology at the Sanjay Gandhi Postgraduate Institute of Medical Sciences and lead investigator in the study.
“In addition to preventing the development of new digital ulcers, tadalafil in combination with other vasodilators marks the beginning of new phase of oral therapeutic options available for severe scleroderma.”
The research has been presented at the American College of Rheumatology Annual Scientific Meeting in Atlanta. (ANI)
- Erectile dysfunction drug found effective against rheumatic diseases - Oct 27, 2008
- Dummy pills work even when they are known to be fake - Dec 23, 2010
- Long-term lung cancer survivors' breathlessness woes - Aug 03, 2010
- Placebos work - even if patients know they are fake - Dec 23, 2010
- Antidepressants could help with stroke recovery - Apr 08, 2011
- Blast of sound can speed up wound healing - Nov 23, 2010
- Sex problem drug can also reduce lower urinary tract infections - Apr 27, 2009
- Molecule from shark cartilage fights joint pain - Sep 18, 2011
- Proximity could be key to success of healing prayer - Aug 06, 2010
- Level of depression determine healing rate of wounds among diabetics - Aug 03, 2010
- Flaxseed no cure for hot flashes during menopause - Jun 06, 2011
- Osteoarthritis supplements have no impact on symptoms - Sep 17, 2010
- Use of nitrates increases bone strength: study - Feb 23, 2011
- Erectile dysfunction drug could help treat bladder outlet symptoms - Apr 27, 2009
- How swallowing worms can heal ulcerative colitis - Dec 02, 2010
Tags: 37 years, blood vessels, difficulty breathing, diffuse scleroderma, duration, finger ulcers, fingers and toes, forearms, internal organs, legs feet, participants, placebo group, raynaud s phenomenon, rheumatic disease, scar tissue, severity, six years, tadalafil, vasodilators